Jiwei Liu
Professor Department Director
Oncology
Dalian Medical University
China
Biography
"Sep.1980-Jul.1986 Norman Bethune Medical University English class of Clinical medine, bachelordegree Sep.1986-Jul.1989 Norman Bethune Medical University Oncology, Masterdegree Sep.2001-Jul.2004 Dalian Medical University Molecular biology, Ph.D. Sep.1989.7up to now The First Affiliated Hospital of Dalian Medical University Department of Oncology,Professor andDepartment Director Jun.1998-Dec.1998 Japan KitakyushuMedical Center Cancer center, Visiting scholar Oct.2006-Mar.2007 Northwestern University, USA Robert Lurrie cancer center, Visiting scholar"
Research Interest
Oncology
Publications
-
Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death. Int J Oncol. 2015, 47: 701-709. IF: 3.025, Corresponding author; doi: 10.3892/ijo.2015.3057.
-
Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cells proliferation via decreasing of FUT4/LeY expression. Int J Oncol. 2015, 46 (4): 1667-76. IF：3.025, Corresponding author; doi: 10.3892/ijo.2015.2886.
-
Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLOS ONE, 2014, 9 (12): e115401. IF：3.534, Corresponding author
